The Illinois Society of Allergy, Asthma and Immunology is a non-profit professional association consisting of allergists and immunologists. We are committed to the educational development of our members for the benefit of the patients in their care. To this end, we improve our knowledge and practice of allergy, asthma and immunology through publications, meetings and conferences relaying advancements in our field. We encourage cooperation and collaboration among those engaged in the field of allergy and immunology affording opportunities to develop professional relationships that will serve as a valuable network of resources within our membership.
To advance the knowledge and practice of allergy and immunology through publications, meetings, and conferences; foster the education of both students, physicians and the public; promote and stimulate allergy and immunology research study; encourage cooperation among those engaged in the field of allergy and immunology; and act in a concerted manner to improve the delivery of high quality allergy care.
Announcements/News/Notes from the President
I hope you all had a wonderful winter season. We enjoyed a excellent winter program in February in Chicago and thank all of our speakers and attendees.
We are welcoming the spring season with characteristic unpredictable weather in Illinois again. The society has planned another great lecture series scheduled for May 1, 2016 with fellowship presentations on their research as well as an exciting lecture by Dr Lee on Food and Gut reactions. An email invitation will be coming to members from the AAAAI directly for this lecture series.
In addition, we are having our annual Spring Social at the Waldorf Astoria on Saturday, April 16, 2016 and look forward to all that can attend.
The ISAAI has been working diligently to plan for discussing exciting topics relevant to us all. In the upcoming year we plan to explore advances in oral immunotherapy options for food allergy, new biologic treatments and allergic contact dermatitis testing and treatment options.
We await legislation decisions on the future of allergen extract compounding and will pass on information to you as it becomes available.
Looking forward to the next season together.
Chhavi Gandhi, MD
Auvi-Q is being recalled for 0.15 mg and 0.3 mg strengths for all current devices including consecutive lot numbers 2299596 through 3037230, which expire March 2016 through December 2016. The products have been found to potentially have inaccurate dosage delivery.
Alternative epinephrine autoinjectors should be ordered. Call the office during normal business hours if you require a new epinphrine autoinjector prescription. 847-832-6000
Sanofi (makers of Auv-Q) state they will reimburse patients for replacement autoinjectors with proof of purchase of the new epinephrine. We are being told by Sanofi representatives that patients should keep current Auvi-Q devices to turn in for reimbursement for replacement epinephrine devices in the future. Reimbursement will only be granted for the number of devices being replaced. The most updated information is available at https://www.auvi-q.com/.
Please email firstname.lastname@example.org or to call 1‑866‑726‑6340, Monday through Friday, 8 a.m.-8 p.m. ET for information on how to return your Auvi‑Q devices.
For epipen coupons, visit www.epipen.com
Dr. Chhavi Gandhi, MD